iBio (IBIO) is not messing around.
What’s up with iBio?
iBio (IBIO) opened at $1.04, which means the stock is up 0.90% from yesterday’s closing price of 1.11. Today, the company has a high of $1.15 and a low of $1.03. The company has a market cap of $114.531 million with a 52-week high of $3.40 and a 52-week low of $0.05.
What about the future foriBio
The high forecast for iBio is 30.00 while the low is 30.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. iBio has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future.. Based on this information IBIO seems to be a safe buy.
iBio is an innovator biologics company developing therapeutics and vaccines for the betterment of human and animal health, including a virus-like particle (VLP) -based vaccine against SARS-CoV-2. iBio’s subsidiary, iBio CDMO is a global leader in plant-based manufacturing. It’s FastPharming™ and FastGlycaneering™ platforms provide contract development and manufacturing services via its 130,000 square foot facility in Bryan, Texas. The speed and scalability of FastPharming make it an ideal choice for other innovator companies who want to rapidly produce COVID-19 biologics.